Economic evaluation of an updated guideline for the empiric treatment of uncomplicated urinary tract infection in women.
Berger
Richard E
RE
D000892:Anti-Infective Agents, Urinary / Q000191:economics* / Q000627:therapeutic use; D016527:Drug Costs; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000175:diagnosis / Q000188:drug therapy / Q000191:economics; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007557:Israel; D009582:Nitrofurantoin / Q000191:economics* / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D012720:Severity of Illness Index; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000191:economics / Q000382:microbiology
D000892:Anti-Infective Agents, Urinary; D009582:Nitrofurantoin